IDENTIFIKASI MASALAH TERKAIT OBAT PADA PASIEN HIPERTENSI KOMORBID ARTHRITIS DI SALAH SATU PUSKESMAS DI KOTA BANDUNG

Authors

  • Vina Septiani Universitas Jenderal Achmad Yani
  • Linda P Suherman Universitas Jenderal Achmad Yani
  • Siti Susiani Universitas Jenderal Achmad Yani
  • Iis Rukmawati UPT Puskesmas Ibrahim Adjie
  • Endah Wahyuni Universitas Jenderal Achmad Yani

DOI:

https://doi.org/10.52434/jfb.v14i1.1943

Keywords:

arthritis, hipertensi, masalah terkait obat

Abstract

Pasien dengan penyakit hipertensi sering disertai dengan penyakit lain, salah satunya arthritis. Pada pasien tersebut telah ditemukan masalah terkait obat seperti efek samping dan interaksi obat. Penelitian ini bertujuan untuk mengidentifikasi Masalah Terkait Obat (MTO) pada pasien hipertensi komorbid arthritis di salah satu Puskesmas di Kota Bandung. Penelitian merupakan penelitian observasional dengan pengambilan data secara retrospektif dan analisis secara deskriptif. Data diambil dari resep pasien yang berobat pada periode Januari-Desember 2019. Kriteria inklusi sampel adalah pasien usia 30-75 tahun, pasien dengan diagnosis hipertensi komorbid arthritis, dan pasien yang berobat pada periode Januari - Desember 2019. Jumlah sampel yang memenuhi kriteria inklusi adalah 44 pasien. Ditemukan masalah terkait obat potensial sebanyak 26 kasus (59,09%) potensi interaksi obat, dengan jenis interaksi farmakodinamik dan tingkat keparahan moderate.

Author Biography

Vina Septiani, Universitas Jenderal Achmad Yani

Fakultas Farmasi

References

Centers for Disease Control and Prevention. What is osteoarthritis (OA). cdc.gov. 2020.

Salem C Ben, Slim R, Fathallah N, Hmouda H. Drug-induced hyperuricaemia and gout. Rheumatol. 2017;1(5):679–88.

Whelton A. Hyperuricemia and hypertension a confluence of concepts. Hypertension. 2012;60(5):1112–3.

Stewart DJ, Langlois V, Noone D. Hyperuricemia and hypertension: links and risks. Integr Blood Press Control. 2019;12:43–62.

Gibson TJ. Hypertension, its treatment, hyperuricaemia and gout. Curr Opin Rheumatol. 2013;25(2):217–22.

Dewi FK, Rini S. Correlation between obesity and hypertension with gout arthritis: a cross-sectional study. In: Proceedings of the 1st international conference on community health (ICCH 2019). 2019.

Badan Penelitian dan Pengembangan Kesehatan. Riset kesehatan dasar (RISKESDAS) 2018. 2018.

Khotib J, Setiawan HU, Nurhan AD, Et.al. Analysis of effectiveness and drug related problems of pain reliever for knee osteoarthritis: weighing clinical risk and benefit. J Basic Clin Physiol Pharmacol. 2020;30(6).

Liberty IA, Pariyana P, Roflin E, Waris L. Determinan kepatuhan berobat pasien hipertensi pada fasilitas kesehatan tingkat I. J Penelit dan Pengemb Pelayanan Kesehat. 2017;1(1):58–65.

Mozaffarian D, J Benjamin E, Go AS, Et.al. Heart disease and stroke statistics 2015 update: a report from the American Heart Association. Am Hear Assoc. 2014;131(4).

Khan MY, Pandit S, Ray S, Et.al. Effectiveness of amlodipine on blood pressure control in hypertensive patients in india: a real-world, retrospective study from electronic medical records. Drugs Real World Outcomes. 2020;7(4):281–93.

Liu R, Mi B, Zhao Y, Et.al. Effect of b vitamins from diet on hypertension. Arch Med Res. 2017;48(2):187–94.

James PA, Oparil S, Carter BL, Et.al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;5(5):507–20.

Baxter K. Stockley’s drug interactions. London: Pharmaceutical Press; 2008. 861–863 p.

Downloads

Published

2023-01-31

Issue

Vol. 14 No. 1 (2023): Jurnal Ilmiah Farmako Bahari

Section

Research Article

License

or all articles published in Jurnal Ilmiah Farmako Bahari, the copyright is retained by the journal. Articles are published under the terms of Creative Commons Attribution-ShareAlike 4.0 International License (CC-BY-SA 4.0) .

For Authors:

  • Any article on the copyright is retained by the author(s).
  • The author grants the journal, right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share work with an acknowledgment of the work authors and initial publications in this journal.
  • Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of published articles of work (eg, post-institutional repository) or publish it in a book, with acknowledgment of its initial publication in this journal.
  • Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their websites) prior to and during the submission process, as can lead to productive exchanges, as well as earlier and greater citation of published work.
  • The article and any associated published material is distributed under the Creative Commons Attribution-ShareAlike 4.0 International License